The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.

Saved in:
Bibliographic Details
Title: The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.
Authors: Alban TJ; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.; Center for Immunotherapy and Precision Oncology, and., Grabowski MM; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA., Otvos B; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA., Bayik D; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute., Wang W; Nationwide Children's Hospital, Institute for Genomic Medicine, Departments of Pediatrics and Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Zalavadia A; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute., Makarov V; Center for Immunotherapy and Precision Oncology, and., Troike K; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute., McGraw M; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA., Rabljenovic A; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute., Lauko A; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute., Neumann C; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute., Roversi G; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute., Waite KA; Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland, USA., Cioffi G; Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland, USA., Patil N; University Hospitals Research and Education Institute, Cleveland, Ohio, USA., Tran TT; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., McCortney K; Departments of Pathology and Neurosurgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA., Steffens A; Departments of Pathology and Neurosurgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA., Diaz CM; Center for Immunotherapy and Precision Oncology, and., Brown JM; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.; Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio, USA.; Case Comprehensive Cancer Center, Cleveland, Ohio, USA., Egan KM; Departments of Pathology and Neurosurgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA., Horbinski CM; Departments of Pathology and Neurosurgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA., Barnholtz-Sloan JS; Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland, USA., Rajappa P; Nationwide Children's Hospital, Institute for Genomic Medicine, Departments of Pediatrics and Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Vogelbaum MA; Departments of Cancer Epidemiology and Neuro-Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Bucala R; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Chan TA; Center for Immunotherapy and Precision Oncology, and.; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA.; Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio, USA.; Case Comprehensive Cancer Center, Cleveland, Ohio, USA., Ahluwalia MS; Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, USA., Lathia JD; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA.; Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio, USA.; Case Comprehensive Cancer Center, Cleveland, Ohio, USA.
Source: JCI insight [JCI Insight] 2023 Jul 10; Vol. 8 (13). Date of Electronic Publication: 2023 Jul 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.160024